<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd"><ep-patent-document id="EP04765595A1" file="04765595.6" lang="en" country="EP" doc-number="1670510" kind="A1" date-publ="20060621" status="n" dtd-version="ep-patent-document-v1-01"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHUPLSK................</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1670510</B110><B130>A1</B130><B140><date>20060621</date></B140><B190>EP</B190></B100><B200><B210>04765595.6</B210><B220><date>20040924</date></B220><B240><B241><date>20060419</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>03021581</B310><B320><date>20030924</date></B320><B330><ctry>EP</ctry></B330></B300><B400><B405><date>20060621</date><bnum>200625</bnum></B405><B430><date>20060621</date><bnum>200625</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  39/395       19850101AFI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/16        19950101ALI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61P  37/00        20000101ALI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61P  35/00        20000101ALI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61P  31/18        20000101ALI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>G01N  33/53        19850101ALI20050406BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C07K  16/18        19950101ALN20050406BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>ANTIKÖRPER GEGEN ANNEXINE, IHRE VERWENDUNG IN DER THERAPIE UND DIAGNOSE, VERWENDUNG VON ANNEXINEN FÜR THERAPIE UND DIAGNOSE</B542><B541>en</B541><B542>ANTIBODIES AGAINST ANNEXINS, USE THEREOF FOR THERAPY AND DIAGNOSIS. USE OF ANNEXINS FOR THERAPY AND DIAGNOSIS.</B542><B541>fr</B541><B542>ANTICORPS DIRIGES CONTRE LES ANNEXINES, LEUR UTILISATION A DES FINS THERAPEUTIQUES ET DIAGNOSTIQUES, UTILISATION DES ANNEXINES A DES FINS THERAPEUTIQUES ET DIAGNOSTIQUES</B542></B540></B500><B700><B710><B711><snm>Krammer, Peter</snm><iid>07404760</iid><irf>31263P EP-WO</irf><adr><str>Wilhelm-Blum-Strasse 14</str><city>69120 Heidelberg</city><ctry>DE</ctry></adr></B711></B710><B720><B721><snm>KRAMMER, Peter</snm><adr><str>Wilhelm-Blum-Strasse 14</str><city>69120 Heidelberg</city><ctry>DE</ctry></adr></B721><B721><snm>WEYD, Heiko</snm><adr><str>Steubenstrasse 14</str><city>69121 Heidelberg</city><ctry>DE</ctry></adr></B721></B720><B740><B741><snm>Weiss, Wolfgang</snm><sfx>et al</sfx><iid>00075614</iid><adr><str>Weickmann &amp; Weickmann 
Patentanwälte 
Postfach 860 820</str><city>81635 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>EP2004010756</anum></dnum><date>20040924</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2005027965</pnum></dnum><date>20050331</date><bnum>200513</bnum></B871></B870></B800></SDOBI></ep-patent-document>